# Retraction Note: Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic–ischemic encephalopathy

**Authors:** Yixin Zhang, Ningbo Xu, Yan Ding, Desislava Met Doycheva, Yiting Zhang, Qian Li, Jerry Flores, Mina Haghighiabyaneh, Jiping Tang, John H. Zhang

PMC · DOI: 10.1038/s41419-025-08183-x · Cell Death & Disease · 2025-10-28

## Full-text entities

- **Genes:** CMKLR1 (chemerin chemokine-like receptor 1) [NCBI Gene 1240] {aka CHEMERINR, ChemR23, DEZ, ERV1, RVER1}, PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 5563] {aka AMPK, AMPK2, AMPKa2, PRKAA}, CAMKK2 (calcium/calmodulin dependent protein kinase kinase 2) [NCBI Gene 10645] {aka CAMKK, CAMKKB}
- **Diseases:** neurological impairments (MESH:D009422), hypoxic-ischemic encephalopathy (MESH:D020925)
- **Chemicals:** Chemerin (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12569030/full.md

---
Source: https://tomesphere.com/paper/PMC12569030